Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

Presentation TCT 2016

Current Indications for TAVR: When Is TAVI Better Than Surgical AVR?

Presenter: Ziyad M. Hijazi, David W.M. Muller

November 01, 2016

Presentation TCT 2016

FFR in the setting of CABG and AS/AVR/TAVR

Presenter: Bernard De Bruyne, Allen Jeremias, Emanuele Barbato

November 01, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Presenter: Niall T. Mulvihill, Hellmuth Weich

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Presenter: Niall T. Mulvihill, Antoniette Neylon

October 31, 2016

Presentation TCT 2016

Debate: TAVR for Low Risk Patients Is It time? NO, We Dont Yet Know if Its as Durable as Surgical AVR!

Presenter: Russell A. Brandwein, Isaac George

October 30, 2016

Presentation

Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR

Presenter: G. Michael Deeb

April 06, 2016

Presentation CTO 2016

Thats How I Do It: Antegrade Dissection/Reentry With a 6 French System

Presenter: Stéphane Rinfret, Simon J. Walsh, Alexandre Avran

February 25, 2016

Presentation

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

Presenter: V. Dayan

December 06, 2015

Presentation Aortovascular 2015

Valve-in-Valve TAVR: Changing the approach to initial AVR surgery?

Presenter: Isaac George

September 19, 2015

Presentation Aortovascular 2015

Mechanical AVR and Root Replacement: When indicated?

Presenter: Michael Argenziano

September 19, 2015

Presentation Aortovascular 2015

Conventional AVR and Root Replacement: Bioprosthetic options

Presenter: Wilson Y. Szeto

September 19, 2015

Presentation TVT 2015

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Presenter: Jonathon A. Leipsic, Jeffrey J. Popma, Michael J. Reardon

June 05, 2015

Presentation

Use of Psoas Muscle Size as a Frailty Assessment Tool for Open and Transcatheter AVR

Presenter: Himanshu J. Patel

April 29, 2015

Presentation TCT 2014

Position Statement: TAVR Will Replace Surgical AVR in Low- and Intermediate-Risk Patients: Cath Labs Get Ready!

Presenter: Kishore J. Harjai, Susheel Kodali

September 14, 2014

Presentation TVT 2014

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Presenter: Michael J. Mack

June 07, 2014

Presentation

PARTNER: Bleeding Complications After Surgical AVR Compared with TAVR

Presenter: P. G?n?reux

December 02, 2013

Presentation

Trans-Catheter Closure of PDA by NitOcclud Coil - Trans-Aortic & Trans-Pulmonary Approach

Presenter: Avraham Lorber

December 02, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Presenter: Daniel Blackman

October 30, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Presenter: Charles Davidson

October 30, 2013

Presentation TCT 2013

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Presenter: Larry Wood

October 29, 2013

Advertisement

Current Indications for TAVR: When Is TAVI Better Than Surgical AVR?

FFR in the setting of CABG and AS/AVR/TAVR

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Debate: TAVR for Low Risk Patients Is It time? NO, We Dont Yet Know if Its as Durable as Surgical AVR!

Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR

Thats How I Do It: Antegrade Dissection/Reentry With a 6 French System

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

Valve-in-Valve TAVR: Changing the approach to initial AVR surgery?

Mechanical AVR and Root Replacement: When indicated?

Conventional AVR and Root Replacement: Bioprosthetic options

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Use of Psoas Muscle Size as a Frailty Assessment Tool for Open and Transcatheter AVR

Position Statement: TAVR Will Replace Surgical AVR in Low- and Intermediate-Risk Patients: Cath Labs Get Ready!

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

PARTNER: Bleeding Complications After Surgical AVR Compared with TAVR

Trans-Catheter Closure of PDA by NitOcclud Coil - Trans-Aortic & Trans-Pulmonary Approach

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content